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ORIGINAL ARTICLE
Benign biliary strictures treated with biodegradable stents in patients with
surgically altered anatomy using double balloon enteroscopy
Outi Lindstr€oma, Marianne Udda, Mia Rainioa, Hannu Nuutinenb, Kalle Jokelainenb and Leena Kyl€anp€a€aa
aGastroenterological Surgery, Abdominal Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland; bGastroenterology,
Abdominal Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
ABSTRACT
Objectives: Surgically altered anatomy complicates endoscopical procedures of pancreatobiliary tree.
Biliary or hepaticojejunal anastomosis strictures have been managed using percutaneous transhepatic
or double balloon enteroscopy (DBE) techniques with multiple plastic stents, or fully covered self-
expandable metal stents. We report the first seven cases with surgically altered anatomy treated with
biodegradable stents with DBE.
Materials and methods: Seven cases with altered anatomy, all with Roux-en-Y hepaticojejunostomy
(HJ), were treated for HJ anastomosis strictures (3 cases) and intrahepatic biliary stricture (4 cases).
Fujifilm DB enteroscope with a 200 cm long and 3.2mm wide working channel was used. Balloon dila-
tations were first performed and then 1–3 biodegradable stents were deployed with a pusher over
a guidewire.
Results: Two patients had HJ due to liver resections, one due to biliary injury in cholecystectomy and
four due to liver transplantation because of primary sclerosing cholangitis (PSC). Median duration of
the procedures was 56min. Deployment of the stents took less than 20min per patient. There were
no stent or cholangiography related adverse events, but one patient required endotracheal intubation
for nose bleeding caused by the placement of nasopharyngeal tube. Two PSC patients had recurrent
cholangitis in the follow up. There was one stent migration in 90day follow up. With all the HJ anasto-
motic strictures resolution of strictures seemed to be achieved.
Conclusions: Treatment of biliary or anastomosis strictures in altered anatomy is complex and time con-
suming. The biodegradable stent, which can be passed through working channel of a long enteroscope,
seems promising in the treatment of these strictures. The benefit is that no stent removal is needed.
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Endoscopic management of pancreaticobiliary duct problems
is technically demanding and time consuming in patients
with surgically altered anatomy. The length of duodenoscope
is usually insufficient for the traditional endoscopic retro-
grade cholangiopancreatography (ERCP) procedures.
Therefore, biliary or hepaticojejunostomy (HJ) anastomotic
strictures have been managed by using percutaneous trans-
hepatic (PT) or double balloon enteroscopy (DBE) techniques,
or surgery. In recent years, DBE-assisted endoscopic retro-
grade cholangiography (ERC) has shown to be efficient and
safe treatment method, and is gaining popularity [1,2].
However, there are still limitations with the use of DBE: the
length of the bowel passage and adhesions can cause inabil-
ity to reach the papilla or pancreaticobiliary anastomosis,
and cannulation is challenging with the lack of appropriate
tools for DBE. In bariatric surgery patients with roux-en-Y
gastric bypass laparoscopy-assisted ERCP has been success-
fully used to overcome these challenges. With this technique
a standard duodenoscope is advanced through a gastros-
tomy into the excluded stomach and duodenum to access
the papilla allowing the use of standard accessories [3].
In conventional ERC, benign biliary strictures (BBS) have
been successfully treated with multiple plastic stents or fully
covered self-expandable metallic stents (fcSEMS) [4–6]. In few
studies, also biodegradable biliary stents have reported to be
feasible and safe in the treatment of BBSs [7–9]. In DBE-ERC
single or multiple plastic stents have been used [2,10] and
we have used fcSEMS [11], in the treatment of BBSs and
anastomotic strictures. Currently, there are no case reports
about using biodegradable stents in DBE-ERC.
Archimedes stent (amg International GmbH, Winsen,
Germany) is a commercially available biodegradable biliary
and pancreatic stent, which has a helical structure allowing
the bile flow on the outer extremity of the stent while sup-
porting the opening of the lumen (Figure 1). The stent has
anatomical shape, tapered tip, and proximal and distal flaps.
There are three types of stents varying from the degradation
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profile: fast (12 days), medium (25 days) and slow (12weeks)
degrading stent, and there are several diameter and length
options available.
With the use of plastic stents and fcSEMSs there is
requirement for repeat conventional or DBE-ERC for stent
removal. The benefit of biodegradable stents is that stent
removal can be avoided. Here we report the first seven cases
with surgically altered anatomy treated with biodegradable
Archimedes stents with DBE-ERC in Helsinki
University Hospital.
Materials and methods
The research was carried out in accordance with the Helsinki
Declaration and approved by the Ethics Committee of the
Helsinki University. The patient characteristics are shown in
Table 1 and the procedural characteristics in Table 2. Seven
nonconsecutive patients with surgically altered anatomy
were treated with slow degrading Archimedes stents
between September 2018 and May 2019. All the patients
had Roux-en-Y HJ. There were three cases with anastomotic
strictures and four cases with intrahepatic strictures. The
median length of procedures was 56min, range 28–119min.
Fujifilm DB enteroscope, EN-580T, with a 200 cm long and
3.2mm wide working channel (Fujifilm Corp. Tokyo, Japan)
was used. In all cases, there was a 145 cm long and 13.2mm
wide TS-13140 overtube with a transparent hood attached to
the tip of the scope. All procedures were performed using
CO2-insufflation, with the patient in prone position, under
conscious sedation controlled by an anesthesiologist and a
nurse. Five patients received antibiotic prophylaxis and two
patients (numbers 1 and 7) had ongoing antibiotic therapy
during the procedures.
All stents were placed by experienced endoscopists. The
largest possible diameter of slow degrading stent to be used
with DB enteroscope is 2.6mm which equals to 8 Fr. The
length of the stent was determined according to the length
and location of the stricture, and the number of the stents
according to the diameter of the stricture. For HJ anastomo-
ses strictures 8–12mm balloon dilations (Boston scientific
CRE TM Wireguided Dilatation catheter 290 cm, Natick, MA,
USA) were first performed, and then 2–3 biodegradable
stents (Archimedes, slow degrading, diameter 2.6mm, length
6–8 cm) were deployed with a 7 Fr pusher (Cook Medical)
over a guidewire (FTE Wildcat, 0.035 inch, length 650 cm; pk
endoskopie GmbH, Hannover, Germany). For intrahepatic
strictures 6–8mm balloon dilations were performed and one
Archimedes stent (slow degrading, diameter 2.6mm, length
6–8 cm) placed with the pusher.
Figure 1. Archimedes stent (amg International GmbH, Winsen, Germany) has a
helical structure allowing the bile flow on the outer extremity of the stent while
supporting the opening of the lumen. The stent has anatomical shape, tapered
tip, and proximal and distal flaps.
Table 2. Procedural characteristics.
Patient Indication Site of stricture Dilation (mm) Length of stent (cm) Diameter of stent (mm) Procedural length (min)
1 Cholangitis, stones Anastomotic 12 6þ 6 2.6 90
2 Cholangitis Intrahepatic 6 8 2.6 46
3 Cholangitis Anastomotic 10 6þ 8 þ 8 2.6 56
4 Cholangitis Anastomotic 8 6þ 6 2.6 52
5 Elevated liver enzymes Intrahepatic 8 8 2.6 28
6 Elevated liver enzymes Intrahepatic 7 6 2.6 119
7 Cholangitis Intrahepatic 6 6 2.6 63
Table 1. Patient characteristics.
Patient Gender Age (yr) Underlying disease Operation, reconstruction Previous ERCs (n) Previous ERC procedures
1 Male 56 Echinococcosis, ALL Liver resection, HJ (Roux-en-Y) 1 ERC
2 Female 49 PSC liver transplantations, HJ (Roux-en-Y) 2 Dilation, plastic stent
3 Female 55 Biliary injury HJ (Roux-en-Y) 1 Dilation, stone removal
4 Female 72 Cholangiocarcinoma Liver resection, HJ (Roux-en-Y) 1 Dilation
5 Female 26 PSC/AIH, UC Liver transplantation, HJ (Roux-en-Y) 1 Dilation
6 Male 30 PSC, UC Liver transplantation, HJ (Roux-en-Y) 1 Dilation
7 Female 34 PSC, UC Liver transplantation, HJ (Roux-en-Y) 3 Dilations
yr: years; ALL: acute lymphocyte leukemia; ERC: endoscopic retrograde cholangiography; HJ: hepaticojejunostomy; PSC: primary sclerosing cholangitis; AIH: auto-
immune hepatitis; UC: ulcerative colitis; n: number.
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Technical success was defined as ability to reach the HJ
anastomosis, and accurate deployment and positioning the
Archimedes stent. Clinical success was defined as absence of
cholangitis and/or no need to other interventions or proce-
dures because of recurrent stricture or stent migration.
Patients
The first patient, 56-year-old male with acute lymphocyte
leukemia, had a liver resection of segments 5–8 and HJ with
segments 2–3 due to echinococcal cysts and strictures in
April 2004. In the beginning of 2018 he suffered from recur-
rent cholangitis and in magnetic resonance cholangiopan-
creatography (MRCP) anastomotic stricture and proximal
stone were suspected. In September 2018, first a conven-
tional ERC via the normal route was done with normal find-
ings, and then 10 days after a DBE-ERC via the HJ route with
findings of ongoing cholangitis, stones and an anastomotic
stricture (Figure 2(a)). A 12mm balloon dilation and stone
removal were performed and two Archimedes stents (diam-
eter 2.6mm and lengths 6 cm) deployed (Figure 2(b)).
The second patient, 49-year-old female with primary scler-
osing cholangitis (PSC), had a liver transplantation with HJ in
2002 and retransplantation in January 2012. She had recur-
rent cholangitis, and in March 2018 a DBE-ERC with dilation
of the right site intrahepatic stricture was performed.
Afterwards, a percutaneous transhepatic (PT) drain was put
due to a left site stricture. In May 2018, second DBE-ERC
with dilation and stenting (8.5 Fr plastic stent) of the left site
intrahepatic stricture and removing of the PT drain was
done. In October 2018, a planned DBE-ERC for retrieval the
plastic stent was performed. There was still a stricture in the
left site intrahepatic bile ducts (Figure 3(a)) and a 6mm bal-
loon dilation was done, and one Archimedes stent (diameter
2.6mm and length 8 cm) deployed (Figure 3(b)).
The third patient, 55-year-old female with biliary stones,
had laparoscopic cholecystectomy and a biliary injury in
2008. First, a choledochojejunostomy was performed, but
because of anastomotic stricture a HJ was done in January
2010. In the beginning of 2018, she had cholangitis and in
MRCP a biliary stone and anastomotic stricture were seen. In
April 2018, a DBE-ERC with dilation of anastomosis and stone
removal was performed. There was still recurrent cholangitis
and in October 2018s DBE-ERC was done. An anastomotic
stricture was found (Figure 4), and a 10mm dilation and
stenting with three Archimedes stents (diameter 2.6mm and
lengths 2 8 cm, 6 cm) were performed (Figures 5 and 6).
The fourth patient, 72-year-old female with cholangiocar-
cinoma, had a liver resection with HJ in June 2013. In May
2014, a DBE-ERC with anastomotic dilation was performed.
After one year, she started to suffer from recurrent cholan-
gitis and in MRCP a new anastomotic stricture was sus-
pected. In October 2018, a DBE-ERC with 8mm dilation of
the stricture was done, and two Archimedes stents (diameter
2.6mm and lengths 6 cm) deployed (Figure 7(a,b)).
The fifth patient, a 26-year-old female with ulcerative col-
itis (UC) and PSC – autoimmune hepatitis (AIH) overlap syn-
drome, had a liver transplantation with HJ in December
2011. In the beginning of 2018, liver enzymes were found
elevated and patient suffered from itching. A DBE-ERC with
dilation of a left site intrahepatic stricture was performed in
March 2018. A right site stricture was also suspected in
MRCP, but that could not be reached or dilated. In
December 2018, a new rise in liver enzymes was noted and
a DBE-ERC with 8mm dilation of the left site intrahepatic
stricture was performed, and one Archimedes stent (diameter
2.6mm, length 8 cm) deployed (Figure 8(a,b)).
The sixth patient, 30-year-old male with UC and PSC, had
a liver transplantation with HJ in August 2014. In 2018, ele-
vated liver enzymes were found and in MRCP a left site
Figure 2. The fluoroscopy views of patient (number 1) with hepaticojejunostomy anastomotic stricture (a) before and (b) after stenting with Archimedes stents.
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intrahepatic stricture was suspected. In October 2018, a DBE-
ERC with dilation of the left site intrahepatic stricture was
performed. There was a new elevation in liver enzymes and
in March 2019s DBE-ERC with 7mm dilation of the left site
intrahepatic stricture was done, and one Archimedes stent
(diameter 2.6mm and length 6 cm) deployed (Figure 9(a,b)).
The seventh patient, 34-year-old female with UC and PSC,
had a liver transplantation with HJ in September 2015. She
suffered from recurrent strictures and cholangitis, and three
DBE-ERCs were performed between July 2017 and February
2019. In the first one, a right site intrahepatic stricture was
dilated, in the second one a left site intrahepatic stricture
and anastomosis were dilated, and in the third one a right
site intrahepatic stricture and anastomosis were dilated. After
the last DBE-ERC a PT drain was put in the right site bile
ducts, and a retransplatation was planned. Patient had
Figure 3. The fluoroscopy views of patient (number 2) with left site intrahepatic stricture (a) before and (b) after stenting with Archimedes stent.
Figure 4. The fluoroscopy view of patient with hepaticojejunostomy anastomotic stricture (number 3).
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discomfort with the PT drain and in May 2019 a new DBE-
ERC with 6mm dilation of the right site intrahepatic stricture
(Figure 10) and stenting with one Archimedes stent (diam-
eter 2.6mm and length 6 cm) was done. The PT drain was
also removed.
Results
All the DBE-ERCs succeeded; the HJ anastomoses were
reached and the Archimedes stents were easily deployed.
One patient (number 6) had a laryngeal spasm during the
procedure, and a nasopharyngeal tube was placed to help
the breathing. That caused nose bleeding and desaturation,
and the patient had to be intubated. Six patients were dis-
charged within 48 h of the procedure, but one patient with
ongoing cholangitis (number 1) needed to stay 5 days in
hospital receiving antibiotics. There were no stent or cholan-
giography related adverse events. The median preprocedural
bilirubin level was 23 umol/l, range 5–42 umol/l and alkaline
phosphatase level 192U/l, range 118–335U/l; and the post-
procedural (after 1 week) 21 umol/l, range 7–31 umol/l and
196U/l, range 131–340U/l, respectively. The follow up data
are shown in Table 3.
30 Day follow up
The patient (number 5) with PSC-AIH overlap syndrome and
liver transplantation had mild rise in liver enzymes after 1
week of discharge. An ultrasound was done with normal
findings, and the liver enzymes decreased spontaneously in
few days.
The patient (number 7) with recurrent strictures and chol-
angitis did well 2 weeks after discharge. After that, she suf-
fered from recurrent cholangitis again and needed treatment
with antibiotics. However, no other procedures were needed,
but the liver retransplantation was planned.
All the other patients had no adverse events after dis-
charging during the 30 days follow up.
90 Day follow up
The patient (number 2) with PSC and liver retransplantation
had cholangitis and a new DBE-ERC was performed in
January 2019. In that procedure, the Archimedes stent was
found migrated in the bowel beside the HJ anastomosis.
Interestingly, the stent had not degraded. There was still an
intrahepatic stricture in the left site, and a plastic stent
(8.5 Fr pigtail) was deployed. The Archimedes stent was
retrieved from the bowel.
The patient (number 3) with biliary injury because of lap-
aroscopic cholecystectomy had upper abdominal pain attacks
after 2.5months of discharging. MRCP was done with normal
findings and a new DBE-ERC in April 2019 with normal find-
ings. The etiology of pain stayed unsolved.
The patient (number 7) with recurrent strictures and chol-
angitis was treated with antibiotics and a liver retransplanta-
tion was done in the beginning of July 2019.
All the other patients did well during the 90 days fol-
low up.
Overall, the technical success was 100% and the clinical
success 71% (5/7 cases) in the 90 day follow up.
Total follow up (until end of June 2020)
The median total follow up was 599 days, range
418–648 days. The patient (number 2) with PSC and liver
retransplantation had recurrent cholangitis, and a second
DBE-ERC after discharging was done in April 2019. The plas-
tic stent was found migrated beside the HJ anastomosis and
no other stent was placed. A thought of third liver
Figure 5. The fluoroscopy view of Archimedes stents of patient with hepatico-
jejunostomy anastomotic stricture (number 3) showing good visibility of
the stents.
Figure 6. The endoscopy view of Archimedes stents of patient with hepaticoje-
junostomy anastomotic stricture (number 3).
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transplantation was woken up. However, the patient had a
gastric bypass operation because of morbid obesity in May
2019, and did well after that, the liver transplantation
thought has been postponed.
All the other patients have been well afterwards.
Discussion
Here we report the first seven patients with surgically altered
anatomy treated successfully with biodegradable Archimedes
stents with DBE-ERC. The stents were easily and fast
deployed (less than 20min), and the median procedural
length was decent (56min). All the patients had Roux-en-Y
HJ, and there were three cases with anastomotic strictures
and four with intrahepatic strictures. Resolution of the stric-
ture was achieved with all anastomotic strictures (follow up
599–648 days). One patient with anastomotic stricture had a
DBE-ERC in 90 day follow up, but this was due to abdominal
pain attacks, and no recurrent stricture was found. The liver
transplantation patients with intrahepatic strictures were
more difficult to treat, and two (one patient had only ele-
vated liver enzymes for a short period) of these patients
Figure 8. The fluoroscopy views of patient (number 5) with left site intrahepatic stricture (a) before and (b) after stenting with Archimedes stent.
Figure 7. The fluoroscopy views of patient (number 4) with hepaticojejunostomy anastomotic stricture (a) before and (b) after stenting with Archimedes stents.
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suffered from recurrent cholangitis and needed more proce-
dures: repeated DBE-ERC because of stent migration and
liver retransplantation. However, the liver retransplantation
was planned even before the DBE-ERC due to recurrent PSC,
and the patient could wait that procedure without uncom-
fortable PT drain because of the Archimedes stent.
There were no stent or cholangiography related adverse
events e.g., perforations or bleedings, but one patient
required endotracheal intubation for nose bleeding caused
by the placement of nasopharyngeal tube. The Archimedes
stents were easily deployed through the long working chan-
nel (200 cm) of the DBE, and the visibility in fluoroscopy was
good (Figure 3). There are three types of stents varying from
the degradation profile (fast, medium and slow degrading)
available, which enables the use for different indications.
There are also wide selection of diameters and lengths of
these stents. The only deficiency seems to be quite short
expiration time. In a pilot study of 53 patients with conven-
tional ERCP these stents have found to be safe and effica-
cious in the treatment of biliary and pancreatic duct
obstructions [9].
In our cases, one patient had stent migration in 90 day
follow up and needed second DBE-ERC with stenting (8.5 Fr
plastic pigtail stent). However, this plastic stent migrated
also in the follow up, so the migration problem could be
more a biliary duct related than stent related. Interestingly,
the migrated Archimedes stent had not degraded, and was
found intact in the bowel after 12weeks. With biodegrad-
able stents some concern has been expressed about the
stent degradation and potential foreign body reaction caus-
ing adverse hyperplasia, stone formation or restricturing of
the duct, but the small human studies with polydioxanone
stents have shown promising results about the safety [8].
Anderloni et al. has published a pilot study of Archimedes
stents and their degradation times. In that study, the deg-
radation time of slow degrading stents was controlled by
abdominal radiograph in two time points, at 3 and 6
months, respectively. At 3 months, 32 of 35 (91.4%) slow
degrading stents were found partially degraded, and at 6
months a complete degradation of the stents was found.
Migration occurred in 3 of 35 (14.3%) of the stents placed
for cholangitis. It was concluded that stent degradation
time is reliable and consistent with expected times accord-
ing to the manufacturer’s information [12]. We did not fol-
low up the patients with MRCP or abdominal radiographs
after discharging, so we can only assume that there were
no other stent degrading related problems because no
other procedures were needed.
Figure 9. The fluoroscopy views of patient (number 6) with left site intrahepatic stricture (a) before and (b) after stenting with Archimedes stent.
Figure 10. The fluoroscopy view of patient (number 7) with right site intrahe-
patic stricture before stenting.
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The European Society of Gastrointestinal Endoscopy
(ESGE) clinical guideline recommends for the treatment of
BBSs temporary insertion of multiple plastic stents with the
maximum number of stents possible every 3–4months for a
total duration of 12months, or of a fcSEMS insertion of an 8-
10mm diameter stent for a dwell stenting period of
6months. For the treatment of benign anastomotic biliary
strictures following orthotopic liver transplantation ESGE sug-
gests temporary insertion of multiple plastic stents pending
further evidence about fcSEMSs [5]. For the treatment of HJ
anastomotic strictures and BBSs in patients with surgically
altered anatomy the published data of different stent types
and stenting times are scarce. In one Japanese retrospective
study of 91 patients with HJ anastomotic stricture a balloon
dilatation was performed as a first-line treatment and plastic
stents were placed for refractory cases. The resolution of an
anastomotic stricture was achieved overall in 70 patients
(76.9%) with a median follow up time of 30.9months, and in
stented patients with the median duration of stent place-
ment of 5.6months [10].
In our patients with HJ anastomotic strictures (n¼ 3), reso-
lution of the stricture seemed to be achieved in all cases
treated with the Archimedes stents. With the slow degrading
stents the stated degradation time is 11–12weeks which
equals to 3 months. In our HJ anastomotic stricture cases, all
patients but one (number 1) had gone through balloon dila-
tation (numbers 3 and 4) before the procedure with balloon
dilatation and Archimedes stent placement. So, the overall
treatment method was similar to that used in the Japanese
study [10] and the treatment period longer than 3 months.
Our group has previously reported the first three cases with
HJ anastomotic strictures treated successfully with fcSEMSs
with stenting period varying between 3 and 12 months [11].
However, therapy with plastic stents or fcSEMSs requires
second DBE-ERC for stent removal. The main benefit with
biodegradable stents is that there is no need for stent
removal, which saves the patient from repeated procedures,
saves time and costs, and decreases potential procedure
related adverse events.
The Archimedes stents were easily deployed through the
long working channel (200 cm) of DBE. However, use of cur-
rently available ERCP devices is limited because of the long
working channel. To overcome this, a short DBE with work-
ing channel length of 152 cm has successfully been used in
DBE-ERC procedures [2]. This short DBE enables the use of
conventional ERCP tools making the procedure much easier.
Biodegradable stents seem promising supplement in the
treatment of pancreaticobiliary strictures with DBE-ERC.
However, this is the first report of seven cases with these
stents. In the future, more controlled studies with adequate
number of patients are needed.
Conclusion
The new biodegradable Archimedes stent, which can be
passed through working channel of a long enteroscope,
seems a promising supplement in the treatment of biliary or
hepaticojejunal anastomosis strictures in altered anatomy.
The benefit is that no stent removal is needed.
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